| Year |
Citation |
Score |
| 2020 |
Dwyer JB, Stringaris A, Brent DA, Bloch MH. Annual Research Review: Defining and treating pediatric treatment-resistant depression. Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 32020643 DOI: 10.1111/Jcpp.13202 |
0.324 |
|
| 2019 |
Dwyer JB, Cardenas A, Franke RM, Chen Y, Bai Y, Belluzzi JD, Lotfipour S, Leslie FM. Prenatal nicotine sex-dependently alters adolescent dopamine system development. Translational Psychiatry. 9: 304. PMID 31740669 DOI: 10.1038/S41398-019-0640-1 |
0.659 |
|
| 2019 |
Kawanishi C, Dwyer J, Bloch MH. 4.63 EFFECT OF KETAMINE ON IMPLICIT ASSOCIATION TESTS EVALUATING ATTITUDES TOWARDS DEPRESSION, SUICIDE, AND SELF-HARM IN ADOLESCENTS WITH MDD Journal of the American Academy of Child & Adolescent Psychiatry. 58: S241. DOI: 10.1016/J.Jaac.2019.08.303 |
0.318 |
|
| 2018 |
Bloch M, Dwyer J. 6.4 Ketamine: An Emerging Treatment for Adolescent Depression Journal of the American Academy of Child & Adolescent Psychiatry. 57: S130. DOI: 10.1016/J.Jaac.2018.07.594 |
0.343 |
|
| 2017 |
Dwyer JB, Beyer C, Wilkinson ST, Ostroff RB, Qayyum Z, Bloch MH. Ketamine as a Treatment for Adolescent Depression: A Case Report. Journal of the American Academy of Child and Adolescent Psychiatry. 56: 352-354. PMID 28335880 DOI: 10.1016/J.Jaac.2017.01.006 |
0.331 |
|
| 2017 |
Dwyer JB, Bloch MH. 2.1 Ketamine As a Treatment for Adolescent Major Depressive Disorder Journal of the American Academy of Child & Adolescent Psychiatry. 56: S176. DOI: 10.1016/J.Jaac.2017.09.081 |
0.358 |
|
| 2017 |
Dwyer J, Sanacora G, Bloch M. 1002. Ketamine as a Treatment for Adolescent Major Depressive Disorder Biological Psychiatry. 81: S405. DOI: 10.1016/J.Biopsych.2017.02.729 |
0.358 |
|
| 2016 |
Dwyer JB, Leslie FM. Adolescent Maturation of Dopamine D1 and D2 Receptor Function and Interactions in Rodents. Plos One. 11: e0146966. PMID 26784516 DOI: 10.1371/Journal.Pone.0146966 |
0.587 |
|
| 2013 |
Cao J, Dwyer JB, Gautier NM, Leslie FM, Li MD. Central myelin gene expression during postnatal development in rats exposed to nicotine gestationally. Neuroscience Letters. 553: 115-20. PMID 23962570 DOI: 10.1016/J.Neulet.2013.08.012 |
0.705 |
|
| 2013 |
Cao J, Wang J, Dwyer JB, Gautier NM, Wang S, Leslie FM, Li MD. Gestational nicotine exposure modifies myelin gene expression in the brains of adolescent rats with sex differences. Translational Psychiatry. 3: e247. PMID 23591971 DOI: 10.1038/Tp.2013.21 |
0.709 |
|
| 2011 |
Wei J, Wang J, Dwyer JB, Mangold J, Cao J, Leslie FM, Li MD. Gestational nicotine treatment modulates cell death/survival-related pathways in the brains of adolescent female rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 91-106. PMID 20426880 DOI: 10.1017/S1461145710000416 |
0.712 |
|
| 2011 |
Cao J, Dwyer JB, Mangold JE, Wang J, Wei J, Leslie FM, Li MD. Modulation of cell adhesion systems by prenatal nicotine exposure in limbic brain regions of adolescent female rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 157-74. PMID 20196919 DOI: 10.1017/S1461145710000179 |
0.734 |
|
| 2009 |
Dwyer JB, McQuown SC, Leslie FM. The dynamic effects of nicotine on the developing brain. Pharmacology & Therapeutics. 122: 125-39. PMID 19268688 DOI: 10.1016/J.Pharmthera.2009.02.003 |
0.688 |
|
| 2008 |
Dwyer JB, Broide RS, Leslie FM. Nicotine and brain development. Birth Defects Research. Part C, Embryo Today : Reviews. 84: 30-44. PMID 18383130 DOI: 10.1002/Bdrc.20118 |
0.71 |
|
| Show low-probability matches. |